Isleworth Healthcare Acquisition Corp. announced the pricing of its upsized $180 million IPO this evening and its units are expected to begin trading on the Nasdaq under the symbol “ISLEU” on Thursday, February 25.
The new company aims to combine with a revenue generating US healthcare company with direct-to-patient initiatives. Isleworth is led by Chairman Allen Weiss and CEO Robert Whitehead alongside CFO and EVP Dan Halvorson.
Total SPAC deal count for 2021 year-to-date is now 176. This offering is expected to close on Monday, March 1.
I-Bankers Securities, Inc. is acting as the sole book-running manager of the offering with Dawson James Securities, Inc. and Northland Capital Markets serving as co-managers. Schiff Hardin LLP is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.